Diabetes-Related Heart Failure - Does Diabetic Cardiomyopathy Exist?

被引:52
作者
Bando, Yasuko K. [1 ]
Murohara, Toyoaki [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan
关键词
Diabetes mellitus; Heart failure; Pathology; Remodeling; LEFT-VENTRICULAR DYSFUNCTION; PRESERVED EJECTION FRACTION; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; DIASTOLIC DYSFUNCTION; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; CARDIAC STEATOSIS; RISK-FACTOR;
D O I
10.1253/circj.CJ-13-1564
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As the link between heart failure (HF) and diabetes mellitus (DM) becomes unignorable, so the need is further increasing for pathological comprehension: What is "diabetic cardiomyopathy (DMC)?" In response to current concern, the most updated guidelines stated by the ACCF/AHA and by the ESC/EASD take one step further, including the definition of DMC, although it is a matter yet to be completed. For more than 40 years, coronary artery disease and hypertension have been considered as the main causes of diabetes-related cardiac dysfunction. HF was originally considered as a result of reduced left ventricular ejection fraction (HF-REF); however, it has been recognized that HF symptoms are often observed in patients with preserved EF (HF-PEF). DMC includes HF with both reduced and preserved entities independent of coronary stenosis and hypertension. Cardiologists are thus facing a sort of chaos without clear guidelines for the "deadly intersection" of DM and HF. Today, the increasing interest and concern have caused DMC to be revisited and the first step in controlling the chaos around DMC is to organize and analyze all of the available evidence from preclinical and clinical studies. This review aims to illustrate the current concepts of DMC by shedding light on the new molecular mechanisms.
引用
收藏
页码:576 / 583
页数:8
相关论文
共 96 条
[1]   Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart [J].
Abel, E. Dale ;
O'Shea, Karen M. ;
Ramasamy, Ravichandran .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (09) :2068-2076
[2]   Relationship of Hemoglobin A1C and Mortality in Heart Failure Patients With Diabetes [J].
Aguilar, David ;
Bozkurt, Biykem ;
Ramasubbu, Kumudha ;
Deswal, Anita .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (05) :422-428
[3]   The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy [J].
Asbun, J ;
Villarreal, FJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) :693-700
[4]   Diabetic cardiomyopathy [J].
Asghar, Omar ;
Al-Sunni, Ahmed ;
Khavandi, Kaivan ;
Khavandi, Ali ;
Withers, Sarah ;
Greenstein, Adam ;
Heagerty, Anthony M. ;
Malik, Rayaz A. .
CLINICAL SCIENCE, 2009, 116 (9-10) :741-760
[5]   Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor.: The DECODE Study [J].
Balkau, B ;
Hu, G ;
Qiao, Q ;
Tuomilehto, J ;
Borch-Johnsen, K ;
Pyörälä, K .
DIABETOLOGIA, 2004, 47 (12) :2118-2128
[6]   Insulin Resistance and Risk of Incident Heart Failure Cardiovascular Health Study [J].
Banerjee, Dipanjan ;
Biggs, Mary L. ;
Mercer, Laina ;
Mukamal, Kenneth ;
Kaplan, Robert ;
Barzilay, Joshua ;
Kuller, Lewis ;
Kizer, Jorge R. ;
Djousse, Luc ;
Tracy, Russell ;
Zieman, Susan ;
Lloyd-Jones, Donald ;
Siscovick, David ;
Carnethon, Mercedes .
CIRCULATION-HEART FAILURE, 2013, 6 (03) :364-370
[7]   Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment [J].
Borlaug, Barry A. ;
Paulus, Walter J. .
EUROPEAN HEART JOURNAL, 2011, 32 (06) :670-+
[8]   Diabetic cardiomyopathy revisited [J].
Boudina, Sihem ;
Abel, E. Dale .
CIRCULATION, 2007, 115 (25) :3213-3223
[9]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[10]   Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes [J].
Brooks, B. A. ;
Franjic, B. ;
Ban, C. R. ;
Swaraj, K. ;
Yue, D. K. ;
Celermajer, D. S. ;
Twigg, S. M. .
DIABETES OBESITY & METABOLISM, 2008, 10 (09) :739-746